Project Specific Information Clause Samples

Project Specific Information. Project specific information such as but not limited to detection limits, reporting limits, estimated values (“J-flag results”), quality control expectations and final reporting requirements shall be communicated either verbally or via email between the PRIME LABORATORY’S project management team and the SUB-LABORATORY’S project management team.

Project Specific Information. Other companies that may have an interest in the meter or meter data: Proposed In-Service Date: If New Construction, Proposed Energizing Date: Proposed Meter Owner: Party that has Maintenance Responsibility: Meter Substation Location: Line Terminal Name: Line Voltage: Measured Voltage: Yes No Estimated Maximum Power (MW): Yes No TBD WAPA Requires MV-90 Data. MV-90 Direct Phone Access: xisting Communication Path to Meter Location (if known): New Communication Path Needed: Communication Path Owner(s) (if known): (If No, ǍIǍ File Required by 0th of Month) Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: Office Phone #: Cell Phone #: E-mail: DUNS Number: Federal Tax ID Number: Contact Name: Title: Street Address: City: State: Zip Code: Office Phone #: Fax #: E-Mail: Submit a completed, signed Meter Application Agreement (Meter Application) and required drawings, with as much information as is known at the time, to: Operations Manager Western Area Power Administration, Rocky Mountain Region ▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇. ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Or E-Mail with Attachments: ▇▇▇_▇▇▇▇▇_▇▇▇▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇

Project Specific Information. (Phase 2) means the document executed by the Parties in accordance with Section 9.8, based on the form attached as Exhibit 7 (Project Specific Information (Phase 2)).

Project Specific Information a. Project Location: The City of Reno, Washoe County, NV.

Project Specific Information. Other companies that may have an interest in the meter or meter data: Proposed In-Service Date: If New Construction, Proposed Energizing Date: Proposed Meter Owner: Party that has Maintenance Responsibility: Meter Substation Location: Line Terminal Name: Line Voltage: Measured Voltage: Estimated Maximum Power (MW): Western Requires MV-90 Data. MV-90 Direct Phone Access: Yes No (If No, Electronic File Required) Existing Communication Path to Meter Location (if known): New Communication Path Needed: Yes No TBD Communication Path Owner(s) (if known):

Project Specific Information. A. Are any of the following genes, viruses, factors or conditions involved? (check all that apply) Yes No a. Deliberate transfer of drug resistance into organisms that do not acquire them naturally? (except for approved host-vector systems that contain antibiotic resistance markers) b. Deliberate transfer of recombinant DNA into humans? c. Use or production of transgenic animals or plants. d. Deliberate formation of recombinant DNA-containing genes that produce vertebrate toxins with LD50 less than 100 ng/kg of body weight? (Specific approval has been given by NIH for the cloning in E. coli K-12 of DNA containing genes coding for the biosynthesis of toxic molecules which are lethal to vertebrates at 100 ng to 100 g per kg of body weight) e. Using human or animal pathogens (Risk Groups 2-4 and restricted agents) as host-vector systems? f. Using human or animal pathogen DNA cloned into non-pathogenic prokaryote or lower eukaryote host-vector systems? g. Using infectious animal or plant DNA or RNA viruses or defective DNA or RNA viruses in the presence of helper virus in tissue culture systems? h. Altering an animal genome by recombinant DNA or testing viable recombinant DNA-modified microorganisms in whole animals? (work with animal pathogens requires a USDA permit) i. Genetic engineering of plants by recombinant DNA methods or use of plants with microorganisms or insects containing recombinant DNA? (work with plant pathogens requires a USDA permit) j. Experiments involving more than 10 liters of culture? k. Deliberate release of recombinant DNA-modified plants or animals into the environment – this requires review by the USDA and the EPA l. Use of human or animal prions? m. Will this require immunization of research team prior to the usage of infectious agents? B. In your judgment, does the proposed project involve any of the following? (check all that apply) Yes No a. Demonstrate how to render a vaccine ineffective? (This would apply to both human and animal vaccines. Production of a vaccine-resistant smallpox virus would be an example of these types of experiments.) ▇. ▇▇▇▇▇▇ resistance to therapeutically useful antibiotics or antiviral agents? (This would apply to therapeutic agents that are used to control disease agents in humans, animals, or crops. An example would be introduction of ciprofloxacin resistance in Bacillus anthracis.) c. Enhance the virulence of a pathogen or render a nonpathogen virulent? (This would apply to plant, animal, and human p...

Project Specific Information. The proposer should carefully review “Exhibit A Scope of Work” in the attached Professional Services Agreement. This exhibit provides background information and directions necessary for proposal preparation.